76
Views
28
CrossRef citations to date
0
Altmetric
Article

Effect of antisecretory factor in ulcerative colitis on histological and laborative outcome: a short period clinical trial

, , &
Pages 1045-1049 | Received 21 Feb 2003, Accepted 30 Jun 2003, Published online: 08 Jul 2009
 

Abstract

Background: The antisecretory factor (AF) is a 41 kD endogenously produced protein capable of mediating protection against diarrhoea diseases and intestinal inflammation. High concentrations of AF‐like proteins are present in egg yolk, and AF can consequently be administrated in the form of egg yolk drinks. In this study, performed in patients suffering from acute onset of ulcerative colitis (UC), we evaluate the influence of orally administrated AF on the histological and clinical laboratory outcome. Methods: A total of 20 patients fulfilled this prospective, double‐blind and randomized protocol. The intake of AF was used as an additive treatment to conventional UC medication. Patient registrations were extended to two outward visits, performed 2–4 and 8–12 weeks after hospital discharge. Results: During AF treatment, a reduction in the histological severity from mucosal biopsies received from the mid‐rectum was found. In addition, a lowering in the inflammatory blood parameters ESR, CRP and orosomucoid was demonstrated. Conclusion: In the AF‐treated group a late and significant lowering of various inflammatory parameters combined with a histological recovery was demonstrated. These findings suggest that administration of AF mediates a long‐lasting anti‐inflammatory effect in cases of acute UC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.